Our goal is to combine modern device technologies with potent neurologically active therapeutics to treat diseases of the nervous system, beginning with hearing-related disorders.  The company will combine the power of tissue-specific drug delivery from partially or completely implantable drug-delivery devices with potent neurologically-active therapeutics.   This targeted, local delivery will allow for treatment with more effective agents while minimizing the risk of side effects associated with systemic delivery.

Our initial program focuses on disorders of the inner ear including tinnitus, Ménière's Disease, and progressive hearing loss.

NeuroSystec, located in the Mann Biomedical Park in Valencia, California, is in the beautiful Santa Clarita Valley just north of Los Angeles and the San Fernando Valley.   The park is also the home to the Alfred E. Mann Foundation, a research and development organization devoted to the developing science of implantable medical devices.  Mann Biomedical Park and the surrounding areas are increasingly becoming the hub of breakthrough device and pharmaceutical research activities.   A number of companies, all founded by the very successful entrepreneur Alfred Mann, in the area include:  Pacesetter, MiniMed, Advanced Bionics, Quallion, Second Sight, Bioness, and MannKind Corporation.

Our Mission

Relieve the suffering of patients with neurological diseases by combining therapeutic agents with drug delivery systems to achieve an increased quality of life. 

People 

Alfred E. Mann - Chairman of the Board 
Thomas J. Lobl - Vice President of Research and Development
 

NeuroSystec is working with Advanced Bionics and the Alfred E. Mann Foundation to develop novel, therapeutic delivery devices for our targeted diseases. 

To develop our platform device and therapeutic technologies, we are in communication with other companies about licensure of intellectual properties.  In order to accelerate the development of new products, we are also interested in establishing research collaborations with government and academic laboratories and research institutes.  Please feel free to contact us if you are interested in pursuing a collaboration.

Privacy Policy

NeuroSystec Corporation feels very strongly about personal privacy rights. Any information of a personal nature that we collect about our clients or patients will be held in the strictest confidence. Only statistics and medical knowledge or information gained from our research that is not tied directly to the identity of specific persons will be released or shared with the medical community or our partners and collaborators without that person's knowledge.

If we feel that a partner or collaborator of ours has medical information or a treatment that would benefit a client or a patient of ours, we will seek permission to share the information with that party before we do so. 

We feel very strongly about your privacy as well as our own.  If we request an email address from you, we will not share or sell your email address, or any piece of personal information, without obtaining your permission in advance.

We may periodically send email to notify clients or patients about important product information, but this will only be on an opt-in basis where you have the ability to decline to receive such notifications. 

From time to time our web servers may place "cookies" on your computer. Our cookies will only be read back by our servers and are for internal use only (for instance, to help you navigate our site, or fill in a form or questionnaire on our site more efficiently). They are never used to collect information about you.

If you have questions concerning our privacy policy, please don't hesitate to contact us.